Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Dovramilast (CC-11050) is an orally active phosphodiesterase 4 (PDE4) inhibitor that reduces the production of pro-inflammatory mediators and cytokines.Dovramilast is used in the study of Mycobacterium tuberculosis infections and lupus erythematosus.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 126.00 | |
2 mg | In stock | $ 186.00 | |
5 mg | In stock | $ 313.00 | |
10 mg | In stock | $ 496.00 | |
25 mg | In stock | $ 953.00 | |
50 mg | In stock | $ 1,490.00 |
Description | Dovramilast (CC-11050) is an orally active phosphodiesterase 4 (PDE4) inhibitor that reduces the production of pro-inflammatory mediators and cytokines.Dovramilast is used in the study of Mycobacterium tuberculosis infections and lupus erythematosus. |
In vivo | In B6D2F1 mice, Dovramilast (5, 25, or 50 mg/kg; oral, single dose) reduces PDE4 expression in the lungs of mice infected with Mycobacterium tuberculosis (mtb)[1]. |
Synonyms | CC-11050 |
Molecular Weight | 472.55 |
Formula | C24H28N2O6S |
CAS No. | 340019-69-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 15 mg/mL (31.74 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Dovramilast 340019-69-4 Metabolism PDE CC-11050 inhibitor inhibit